We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$515M
AUM Growth
+$76.5M
Cap. Flow
+$39.5M
Cap. Flow %
7.68%
Top 10 Hldgs %
25.13%
Holding
215
New
32
Increased
93
Reduced
54
Closed
32

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Healthcare 14.56%
3 Industrials 8.47%
4 Financials 8.15%
5 Consumer Discretionary 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
101
CareDx
CDNA
$2.45B
$671K 0.13%
17,686
+6,525
+58% +$220K
NGVT icon
102
Ingevity
NGVT
$2.62B
$667K 0.13%
13,496
-817
-6% -$46.1K
FR icon
103
First Industrial Realty Trust
FR
$8.4B
$663K 0.13%
16,652
-3,276
-16% -$135K
IJH icon
104
iShares Core S&P Mid-Cap ETF
IJH
$128B
$662K 0.13%
17,850
+5,150
+41% +$193K
INDA icon
105
iShares MSCI India ETF
INDA
$6.58B
$654K 0.13%
19,312
+1,086
+6% +$35.6K
CUTR
106
DELISTED
Cutera, Inc.
CUTR
$651K 0.13%
34,295
+531
+2% +$8.2K
CNMD icon
107
CONMED
CNMD
$1.48B
$648K 0.13%
8,244
+1,242
+18% +$101K
PETQ
108
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$638K 0.12%
19,370
+1,025
+6% +$34.1K
PEGA icon
109
Pegasystems
PEGA
$5.15B
$624K 0.12%
10,314
+1,266
+14% +$72.8K
OMCL icon
110
Omnicell
OMCL
$1.69B
$621K 0.12%
8,321
+2,290
+38% +$159K
TNDM icon
111
Tandem Diabetes Care
TNDM
$1.63B
$620K 0.12%
5,462
-662
-11% -$69.6K
PFF icon
112
iShares Preferred and Income Securities ETF
PFF
$13.3B
$591K 0.11%
16,224
+8,365
+106% +$301K
VIAV icon
113
Viavi Solutions
VIAV
$10.6B
$560K 0.11%
47,770
+1,598
+3% +$20.7K
PGTI
114
DELISTED
PGT, Inc.
PGTI
$543K 0.11%
31,020
+8,562
+38% +$150K
SSB icon
115
SouthState Bank Corp
SSB
$10.7B
$542K 0.11%
11,239
CHDN icon
116
Churchill Downs
CHDN
$6.17B
$538K 0.1%
6,568
-1,032
-14% -$80K
CDMO
117
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$523K 0.1%
+68,677
New +$520K
JYNT icon
118
The Joint Corp
JYNT
$123M
$522K 0.1%
30,024
+3,843
+15% +$62.8K
LSCC icon
119
Lattice Semiconductor
LSCC
$18.4B
$520K 0.1%
17,961
+1,154
+7% +$33.9K
CLDR
120
DELISTED
Cloudera, Inc.
CLDR
$514K 0.1%
47,211
-3,286
-7% -$38.1K
MTZ icon
121
MasTec
MTZ
$22.6B
$505K 0.1%
11,960
+3,825
+47% +$164K
NUAN
122
DELISTED
Nuance Communications, Inc.
NUAN
$505K 0.1%
15,229
-4,772
-24% -$138K
KBH icon
123
KB Home
KBH
$3.42B
$497K 0.1%
12,940
-1,528
-11% -$53.4K
XIFR
124
XPLR Infrastructure LP
XIFR
$1.08B
$497K 0.1%
8,294
+993
+14% +$58.7K
COLM icon
125
Columbia Sportswear
COLM
$2.88B
$496K 0.1%
5,707
-357
-6% -$29.6K

Similar funds

Greenwood Capital Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Greenwood Capital Associates held 215 positions worth $515M, up 17% from $438M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Greenwood Capital Associates deployed $39.5M of net new capital in Q3 2020, opening 32 new positions and adding to 93 existing holdings. Its largest new stake was S&P Global: 18,256 shares worth $6.58M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $8.21M trimmed.

  • Greenwood Capital Associates's largest Q3 2020 buy was S&P Global: 18,256 shares worth $6.58M.
  • Greenwood Capital Associates added most to Neurocrine Biosciences in Q3 2020, an estimated $6.44M increase.
  • Greenwood Capital Associates's biggest Q3 2020 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $8.21M.
  • Greenwood Capital Associates fully exited Invesco S&P 500 Equal Weight ETF in Q3 2020, selling an estimated $3.85M.
  • Greenwood Capital Associates's ten largest holdings make up 25% of its $515M portfolio in Q3 2020.
  • Greenwood Capital Associates opened 32 new positions and closed 32 in Q3 2020.
  • Greenwood Capital Associates's portfolio value rose 17% quarter-over-quarter to $515M.

Based on Greenwood Capital Associates's 13F filing for Q3 2020, filed 12 Nov 2020.